Thomas C. Freyman, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 17,472 shares at $49.04 ($851K) on 2007-01-03, disclosed to the SEC on 2007-01-05.
Scheduled sale ($851k) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.71 | 17,406 | $848K | 99.6% |
| 2 | $49.04 | 66 | $3K | 0.4% |
| Total | $48.71 avg | 17,472 | $851K | 100% |
| Filing → |
| TEN | BUY | 2018-08-10 | $222K | — | Filing → |
| ABT | SELL | 2014-03-04 | $117K | — | Filing → |
| TEN | BUY | 2013-05-03 | $57K | — | Filing → |